文献速递神经介入CTMRPET

使用3,4-二羟基-6-[18F]氟-L-苯丙氨酸正电子发射断层扫描对高级别胶质瘤进行剂量绘画容积旋转调强放疗

Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography.
PubMed 文献 · Br J Radiol · 2019-05-14

本研究对10例高级别胶质瘤患者术后放疗计划进行回顾性分析,比较基于MRI的常规容积旋转调强放疗计划与基于18F-FDOPA PET/CT生物靶区剂量提升的剂量绘画计划。结果显示剂量绘画计划在生物靶区覆盖良好的同时,危及器官最大剂量和等效均匀剂量无显著差异,作者认为该策略可行。

要点

  • 18F-FDOPA PET/CT可用于构建高级别胶质瘤生物靶区并指导剂量绘画。
  • 剂量绘画计划中生物靶区V95%中位数>99.2%,覆盖良好。
  • 剂量绘画未显著增加危及器官最大剂量和等效均匀剂量。

核心结论

  • 使用商用治疗计划软件对高级别胶质瘤进行剂量绘画可行,生物靶区覆盖良好且危及器官剂量无显著变化。

研究设计与样本

  • 回顾性研究,纳入10例高级别胶质瘤患者,为术后放疗计划采集CT、MRI和18F-FDOPA PET/CT图像,为每例患者生成两种容积旋转调强放疗计划。

诊断标准与关键数值

  • 常规计划为MRI勾画计划靶区给予60 Gy分30次;剂量提升计划为生物靶区最大剂量80 Gy分30次;生物靶区通过线性二次模型对18F-FDOPA PET/CT摄取进行阈值分割生成,该模型假设示踪剂摄取与肿瘤细胞密度线性相关。

临床应用与阅片要点

  • 剂量绘画计划中计划靶区V95%中位数为99.6%,无剂量绘画计划为99.5%;生物靶区V95%中位数>99.2%;危及器官最大剂量和等效均匀剂量在两种计划间无显著差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To determine whether dose painting with volumetric modulated arc therapy for high-grade gliomas using 3,4-dihydroxy-6-[18F]fluoro-l-phenylalanine (18F-FDOPA) positron emission tomography (PET) could achieve dose-escalated coverage of biological target volumes (BTVs) without increasing the dose to cranial organs at risk (OARs).

METHODS: 10 patients with high-grade gliomas underwent CT, MRI, and 18F-FDOPA PET/CT images for post-operative radiation therapy planning. Two volumetric modulated arc therapy plans were retrospectively generated for each patient: a conventional plan with 60 Gy in 30 fractions to the planning target volume delineated on MRI and a dose-escalated plan with a maximum dose of 80 Gy in 30 fractions to BTVs. BTVs were created by thresholding 18F-FDOPA PET/CT uptake using a linear quadratic model that assumed tracer uptake was linearly related to tumour cell density. The maximum doses and equivalent uniform doses of OARs were compared.

RESULTS: The median volume of the planning target volume receiving at least 95% of the prescribed dose (V 95%) was 99.6% with and 99.5% without dose painting. The median V 95% was >99.2% for BTVs. The maximum doses and equivalent uniform doses to the OARs did not differ significantly between the conventional and dose-painted plans.

CONCLUSION: Using commercially available treatment planning software, dose painting for high-grade gliomas was feasible with good BTV coverage and no significant change in the dose to OARs.

ADVANCES IN KNOWLEDGE: A novel treatment planning strategy was used to achieve dose painting for gliomas with BTVs obtained from 18F-FDOPA PET/CT using a radiobiological model.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Kosztyla R, Raman S, Moiseenko V, et al. Dose-painted volumetric modulated arc therapy of high-grade glioma using 3,4-dihydroxy-6-[18F]fluoro-L-phenylalanine positron emission tomography. Br J Radiol. 2019. PMID: 31017449. doi:10.1259/bjr.20180901

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。